NPCU.F Stock Overview
Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Allon Therapeutics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 9,900.00% |
| 3 Year Change | -99.00% |
| 5 Year Change | 900.00% |
| Change since IPO | -99.95% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| NPCU.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 1.2% |
| 1Y | 9,900.0% | 0.7% | 24.9% |
Return vs Industry: NPCU.F exceeded the US Biotechs industry which returned 1.1% over the past year.
Return vs Market: NPCU.F exceeded the US Market which returned 24.7% over the past year.
Price Volatility
| NPCU.F volatility | |
|---|---|
| NPCU.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NPCU.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NPCU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | n/a | www.allontherapeutics.com |
Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004.
Allon Therapeutics Inc. Fundamentals Summary
| NPCU.F fundamental statistics | |
|---|---|
| Market cap | US$14.11k |
| Earnings (TTM) | -US$9.63m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs NPCU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPCU.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$13.21m |
| Earnings | -CA$13.21m |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NPCU.F perform over the long term?
See historical performance and comparison